NEW YORK (GenomeWeb) – Cepheid announced today that its qualitative HIV-1 assay has achieved CE-IVD status. The assay, called Xpert HIV-1 Qual, runs on the firm's GeneXpert platform and detects nucleic acid of the virus from blood samples in around 90 minutes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.